-
Paediatric patients with heterozygous familial hypercholesterolaemia treated with evolocumab for 80 weeks (HAUSER-OLE): a single-arm, multicentre, open-label extension of HAUSER-RCT
Santos, R. D., Ruzza, A., Hovingh, G. K., Stefanutti, C., Mach, F., Descamps, O. S., Bergeron, J., Wang, B., Bartuli, A., Buonuomo, P. S., Greber-Platzer, S., Luirink, I., Bhatia, A. K., Raal, F. J., Kastelein, J. J. P., Wiegman, A. & Gaudet, D., 1 Oct 2022, In: The Lancet Diabetes and Endocrinology. 10, 10, p. 732-740 9 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Intima-media thickness in treated and untreated patients with and without familial hypercholesterolemia: A systematic review and meta-analysis
van Bergen en Henegouwen, K., Hutten, B. A., Luirink, I. K., Wiegman, A., de Groot, E. & Kusters, D. M., 1 Mar 2022, In: Journal of clinical lipidology. 16, 2, p. 128-142 15 p.Research output: Contribution to journal › Review article › Academic › peer-review
-
Marked plaque regression in homozygous familial hypercholesterolemia
Reeskamp, L. F., Nurmohamed, N. S., Bom, M. J., Planken, R. N., Driessen, R. S., van Diemen, P. A., Luirink, I. K., Groothoff, J. W., Kuipers, I. M., Knaapen, P., Stroes, E. S. G., Wiegman, A. & Hovingh, G. K., 1 Jun 2021, In: Atherosclerosis. 327, p. 13-17 5 p.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
